Pharmafile Logo
Pharmafocus logo
Advanced Search

coronavirus

Showing 15 posts of 362 posts found.

800px-thumbnail

COVID-19 patients are experiencing long-term effects from the virus

August 13, 2020
COVID, COVID-19, coronavirus

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.

News
fake_news

Coronavirus fake news has led to hundreds of deaths, according to a new study

August 13, 2020
Medical Communications COVID, coronavirus, fake news

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

August 12, 2020
Research and Development COVID-19, coronavirus, covid news

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …

News
fda

Gilead applies for FDA approval to treat coronavirus patients with remdesivir

August 11, 2020
Manufacturing and Production COVID-19, Gilead, coronavirus

Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …

News
vxxxxeer

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

August 11, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

News
droxtchcc

Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020

August 10, 2020
Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine

More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …

News
vxxxxeer

Over a third of Americans say they won’t take a coronavirus vaccine

August 10, 2020
Sales and Marketing COVID-19, coronavirus, vaccines

35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …

News
j_and_j

US to pay Johnson and Johnson $1 billion for COVID-19 vaccine

August 6, 2020
Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …

News
800px-nhs_nnuh_entrance

NICE advises GPs to stop prescribing opioids for chronic pain

August 5, 2020
Business Services, Research and Development COVID-19, coronavirus

The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020
Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …

News
uk_gobtg

UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns

August 4, 2020
Manufacturing and Production UK, brexit, coronavirus

The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …

News
eu_flag

EU agrees deal with Sanofi for COVID-19 vaccine supply

August 3, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …

News
covid_test

England to start using two new 90-minute COVID-19 tests in preparation for the winter

August 3, 2020
Sales and Marketing COVID-19, coronavirus

Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …

News
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020
Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …

News

Latest content

GSK’s Jemperli approved in EU as treatment for endometrial cancer

December 11, 2023

Daiichi Sankyo shares results for Ezharmia as lymphoma treatment

December 11, 2023

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023